Market Closed - OTC Markets 03:53:39 2024-04-23 pm EDT 5-day change 1st Jan Change
0.0906 USD -4.29% Intraday chart for Sonendo, Inc. -3.31% -56.86%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sonendo, Inc. Announces Sadie Stern Not to Stand for Reelection to the Board of Directors CI
North American Morning Briefing : Stock Futures -2- DJ
Transcript : Sonendo, Inc., Q4 2023 Earnings Call, Mar 11, 2024
Sonendo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Sonendo, Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2024 CI
Sonendo, Inc. Announces Impairment of Long-Lived Assets for the Three Months Ended December 31, 2023 CI
Sonendo, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Sonendo, Inc. Announces CFO Changes CI
Sonendo, Inc. to Amend its Amended and Restated Credit Agreement and Guaranty with Perceptive Credit Holdings, LP CI
Valsoft Corporation Inc. acquired TDO Software from Sonendo, Inc. for approximately $16 million. CI
Sonendo, Inc. Announces Resignation of Karen Mcginnis as Director and Member of the Audit Committee and Compensation Committee, Effective March 31, 2024 CI
Sonendo, Inc. Partners with Best for Dentistry to Continue Expanding Access to the Innovative GentleWave Procedure CI
Sonendo, Inc.(OTCPK:SONX) dropped from S&P TMI Index CI
Sonendo, Inc. Primary Exchange Listing will Change to OTCQX Marketplace from New York Stock Exchange CI
Sonendo Receives Suspension Notice From NYSE MT
Sonendo, Inc. Announces Resignation of Michael Smith as Chief Commercial Officer Effective December 1, 2023 CI
Goldman Sachs Adjusts Sonendo's Price Target to $1.50 From $1.75, Maintains Buy Rating MT
Morgan Stanley Adjusts Price Target on Sonendo to $4.60 From $5, Maintains Equal-Weight Rating MT
Transcript : Sonendo, Inc., Q3 2023 Earnings Call, Nov 08, 2023
Earnings Flash (SONX) SONENDO Reports Q3 Revenue $10.4M, vs. Street Est of $10.4M MT
Sonendo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Sonendo Expects Q3 Revenue of $10.4 Million; Maintains 2023 Revenue Outlook MT
Sonendo, Inc. Provides Revenue Guidance for the Third Quarter and Full Year 2023 CI
Sonendo Signs Partnership Agreements to Expand Access to GentleWave Procedure for Root Canal Treatment MT
Sonendo, Inc. Announces New Partnership Agreements with Two Leading Specialty DSOs to Expand Access to the GentleWave® Procedure for Elevated Root Canal Treatment CI
Chart Sonendo, Inc.
More charts
Sonendo, Inc. is a commercial-stage medical technology company focused on saving teeth from tooth decay. The Company develops and manufactures the GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure. Its Product segment includes the sales of the GentleWave System console and related accessories and instruments. The Company also offers ancillary products, such as SoundSeal and its Sonendo-branded liquid solution of ethylenediaminetetraacetic acid (EDTA). SoundSeal is a material used during the GentleWave Procedure to build and create a sealing platform on the top of the crown.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.0947 USD
Average target price
0.25 USD
Spread / Average Target
+164.10%
Consensus
  1. Stock Market
  2. Equities
  3. SONX Stock
  4. News Sonendo, Inc.
  5. Earnings Flash (SONX) SONENDO Posts Q3 Revenue $9.8M